Second-Line Chemotherapy in Advanced Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|64|2|61-69

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.64, Iss.2, 2000-05, pp. : 61-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 376-381

Karger

Access to resources Recommend Favorite

Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3290-3297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short Time to Progression under First-Line Chemotherapy Is a Negative Prognostic Factor for Time to Progression and Residual Survival under Second-Line Chemotherapy in Advanced Pancreatic Cancer

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 335-339

Karger

Access to resources Recommend Favorite

Docetaxel: Efficacy in First- and Second-Line Therapy of Advanced Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 1-3

Karger

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

By  

Oncology Research and Treatment, Vol. 26, Iss. 3, 2003-07 ,pp. : 255-258

Karger

Access to resources Recommend Favorite